Ameriprise’s Research Frontiers REFR Stock Holding History

Ameriprise’s Portfolio REFR Stock Details REFR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-100	Closed	–	–	5381
2013 Q3	$0	Hold	100	–	–	﹤0.01%	5662
2013 Q2	$0	Buy	+100	New	+$396	﹤0.01%	5571

Other funds holding REFR

GCM

Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HCS

Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise's REFR Position: Q4 2013 in Review

Ameriprise sold out of Research Frontiers (REFR) in Q4 2013, closing a stake of 100 shares.

Ameriprise first reported a position in REFR in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q3 2013. 42 funds tracked by Wall St. Rank hold REFR as of Q4 2013.

Ameriprise reported no remaining Research Frontiers position as of Q4 2013 after selling out during the quarter.
Ameriprise sold 100 Research Frontiers shares in Q4 2013.
Ameriprise first reported a position in Research Frontiers in Q2 2013 and held it in 2 quarters.
Ameriprise's Research Frontiers position peaked at $0 in Q3 2013.
42 funds tracked by Wall St. Rank held Research Frontiers as of Q4 2013.

Based on Ameriprise's 13F filing for Q4 2013, filed 14 Feb 2014.